Loading…

The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women

Summary objective  Osteoprotegerin (OPG) is a recently identified cytokine that acts as a decoy receptor for the RANK ligand. Moreover, OPG has been shown to be an important inhibitor of osteoclastogenesis in animal models. However, the relationship between circulating OPG levels and female bone sta...

Full description

Saved in:
Bibliographic Details
Published in:Clinical endocrinology (Oxford) 2004-08, Vol.61 (2), p.244-249
Main Authors: Oh, Ki Won, Rhee, Eun Jung, Lee, Won Young, Kim, San Woo, Oh, Eun Sook, Baek, Ki Hyun, Kang, Moo Il, Choi, Moon Gi, Yoo, Hyung Joon, Park, Sung Woo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary objective  Osteoprotegerin (OPG) is a recently identified cytokine that acts as a decoy receptor for the RANK ligand. Moreover, OPG has been shown to be an important inhibitor of osteoclastogenesis in animal models. However, the relationship between circulating OPG levels and female bone status in human populations is unclear. In this study we undertook to investigate the relationship between circulating OPG levels and bone mineral metabolism in healthy women. patients and measurements  Our subjects were 287 women aged 37–73 years (mean age 51·5 years). The serum concentrations of OPG were determined by enzyme‐linked immunosorbent assay (ELISA). The biochemical markers of bone turnover and FSH were measured using standard methods. Bone mineral densities at the lumbar spine and femoral neck were measured by dual‐energy X‐ray absorptiometry. results  Postmenopausal women had a significantly higher mean value of serum OPG than premenopausal women (1358·5 ± 32·5 pg/ml vs. 1228·8 ± 33·3 pg/ml, P 
ISSN:0300-0664
1365-2265
DOI:10.1111/j.1365-2265.2004.02090.x